Product & Service
Pop up
About us
Products
R&D
Certificate
News
Contact us
中文版
Oncology
Bevacizumab
Name: Bevacizumab
CAS :216974-75-3
Registration :
Structural formula:
Previous:
Trastuzumab
Next:
Pertuzumab
line
Copyright(C)2020,
Hangzhou Jinlan Pharm-Drugs Technology Co., Ltd.
All Rights Reserved.